BioCentury
ARTICLE | Clinical News

Cogane: Completed Phase II enrollment

April 23, 2012 7:00 AM UTC

Phytopharm completed enrollment of at least 408 patients in the double-blind, placebo-controlled, international Phase II CONFIDENT-PD trial evaluating 3 doses of once-daily oral Cogane for 28 weeks. ...